Thought Leadership

Are you looking to raise capital in a challenging economic climate? Hiring the right executive leadership can be critical to securing funding. We explore why now is the best time to hire board members and C-suite executives with specific skills to engage investors and how this investment can pay dividends in the long run.

Critical early hires like the CBO and CMO can be make-or-break moments for early-stage biotechs. Andy Cronin offers a guide for companies wrestling with tough choices about resource investment in leadership and points to the often-overlooked role of interim hires.

Biotech layoffs worldwide are causing some reason for panic amongst those in the industry. Yet, is this simply a return to normalcy regarding hiring cadence? And what does the outlook for the industry look like? Continue reading to learn more.

One month after launch, the LifeSci Accelerate search offering for early-stage biotechs is already producing wins for clients. We’ll bring the program to industry events in Q3 and Q4 of this year.

Discover what makes an exceptional leader in the biotech sector and when it might be time to transition a founder out.

In the last five years, digital healthcare has experienced industry-defining innovation – shaping the future of global medicine. Discover the branches of digital health making the most significant impact – particularly in the European market.

Investors are removing money from biotech funds, are being lukewarm on IPOs, and have been doubtful of some startups – but why?